Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy.
Detection of tumor response to a vascular disrupting agent by hyperpolarized 13C magnetic resonance spectroscopy.
复制标题
DOI:
10.1158/1535-7163.mct-10-0706
复制
发表时间:
2010-12
影响因子:
5.7
通讯作者:
Brindle KM
中科院分区:
文献类型:
--
作者:
Bohndiek SE;Kettunen MI;Hu DE;Witney TH;Kennedy BW;Gallagher FA;Brindle KM
Nuclear spin hyperpolarization can increase dramatically the sensitivity of the 13C magnetic resonance experiment, allowing dynamic measurements of the metabolism of hyperpolarized 13C-labeled substrates in vivo. Here, we report a preclinical study of the response of lymphoma tumors to the vascular disrupting agent, combretastatin-A4-phosphate, as detected by measuring changes in tumor metabolism of hyperpolarized [1-13C]pyruvate and [1,4-13C2]fumarate. These measurements were compared with dynamic contrast agent enhanced magnetic resonance imaging (DCE-MRI) measurements of tumor vascular function and diffusion-weighted MRI (DW-MRI) measurements of the tumor cell necrosis that resulted from subsequent loss of tumor perfusion. The rate constant describing flux of hyperpolarized 13C label between [1-13C]pyruvate and lactate was decreased by 34% within 6 h of combretastatin-A4-phosphate treatment and remained at this lower level at 24 h. The rate constant describing production of labeled malate from hyperpolarized [1,4-13C2]fumarate increased 1.6-fold and 2.5-fold at 6 and 24 h after treatment respectively and correlated with the degree of necrosis detected in histological sections. While DCE-MRI measurements showed a substantial reduction in perfusion at 6 h after treatment, which had recovered by 24 h, diffusion-weighted imaging showed no change in the apparent diffusion coefficient of tumor water at 6 h after treatment, although there was a 32% increase at 24 h (p<0.02), when regions of extensive necrosis were observed by histology. Measurements of hyperpolarized [1-13C]pyruvate and [1,4-13C2]fumarate metabolism may provide therefore a more sustained and sensitive indicator of response to a vascular disrupting agent than DCE-or DW-MRI respectively.